03929cam a2200589Ii 4500 ocn898423398 OCoLC 20190328114810.0 m o d cr ||||||||||| 141220t20152015enka ob 000 0 eng d 2014957608 EBLCP eng rda pn EBLCP N$T OCLCQ YDXCP OPELS OCLCF MMU OCLCO CHVBK OCLCQ CNCGM OCLCO MERER OCLCO OCLCQ OCLCA U3W OCLCO D6H OCLCQ AU@ OCLCO OCLCQ WYU CUY LOA ZCU USU MERUC OCLCO ICG K6U COCUF OCLCQ VT2 DKC 899567948 904419910 1088981102 9780081003473 (electronic bk.) 0081003471 (electronic bk.) 9780081003466 (print) 0081003463 (print) (OCoLC)898423398 (OCoLC)899567948 (OCoLC)904419910 (OCoLC)1088981102 RM263 QV 267 MED 071000 bisacsh 615.58 23 Lu, Da-Yong, 1962- author. Personalized cancer chemotherapy : an effective way of enhancing outcomes in clinics / [electronic resource] Da-Yong Lu. Cambridge, UK : Elsevier/Woodhead Publishing, [2015] �2015 1 online resource (85 pages) : illustrations (some color). text txt rdacontent computer c rdamedia online resource cr rdacarrier Woodhead Publishing series in biomedicine ; 720 Includes bibliographical references. Introduction -- Drug sensitivity testing -- Individualized cancer chemotherapy via cancer biomarkers or bioinformatics detection -- Pharmacogenetics -- Individualized antimetastatic therapy [1-2] -- Drug combinations -- Assistant chemotherapy -- Cost-effectiveness considerations -- Discussion -- Conclusion. Individualized cancer chemotherapy (ICC) has been designed to meet the requirement of selecting anticancer drugs in clinics and attracting increasing attentions in medical circle and will show more beneficial outcome in the future if we stick on these researches. Personalized Cancer Chemotherapy addresses and reviews this issue by discussing many existing specific strategies of ICC, including drug sensitivity testing, cancer biomarker detections, cancer biomarker-oriented therapy, anticancer drug pharmacogenetics, cancer metastasis therapy, anticancer drug combinations, assistant therapy, mathematics, and computational analysis of cancer malignancy and drug responses, cost effective and finally studies of relationship between different ICC strategies. The relationship between drug response and these techniques or methods is in-depth analyzed, discussed and highlight. Many longstanding key debates and future trends are also intensively discussed, highlighted and debuted with new twists. Online resource; title from electronic title page (ebrary, viewed on April 3, 2015).). Chemotherapy. Cancer Treatment. MEDICAL Pharmacology. bisacsh Cancer Treatment. fast (OCoLC)fst00845538 Chemotherapy. fast (OCoLC)fst00853595 Neoplasms drug therapy. (DNLM)D009369Q000188 Antineoplastic Agents. (DNLM)D000970 Drug-Related Side Effects and Adverse Reactions. (DNLM)D064420 Pharmacogenetics methods. (DNLM)D010597Q000379 Precision Medicine methods. (DNLM)D057285Q000379 Electronic books. Electronic books. lcgft Print version: Personalized Cancer Chemotherapy. Woodhead Pub Ltd 2014 9780081003466 (DLC) 2014957608 (OCoLC)898160939 Woodhead Publishing series in biomedicine ; no. 720. 2050-0289 ScienceDirect http://www.sciencedirect.com/science/book/9780081003466 247030 247030